U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C14H12ClN3OS
Molecular Weight 305.783
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2-(((4-CHLORO-3-METHYLPYRIDIN-2-YL)METHYL)SULFINYL)-1H-BENZIMIDAZOLE, (±)-

SMILES

CC1=C(Cl)C=CN=C1C[S+]([O-])C2=NC3=CC=CC=C3N2

InChI

InChIKey=RAPCQINSRSZSKF-UHFFFAOYSA-N
InChI=1S/C14H12ClN3OS/c1-9-10(15)6-7-16-13(9)8-20(19)14-17-11-4-2-3-5-12(11)18-14/h2-7H,8H2,1H3,(H,17,18)

HIDE SMILES / InChI

Approval Year

Unknown
139594
Name Type Language
2-(((4-CHLORO-3-METHYLPYRIDIN-2-YL)METHYL)SULFINYL)-1H-BENZIMIDAZOLE, (±)-
Systematic Name English
LANSOPRAZOLE IMPURITY F [EP IMPURITY]
Common Name English
RABEPRAZOLE RELATED COMPOUND F [USP IMPURITY]
Common Name English
RABEPRAZOLE RELATED COMPOUND F
USP-RS  
Common Name English
2-(((4-CHLORO-3-METHYLPYRIDIN-2-YL)METHYL)SULFINYL)-1H-BENZIMIDAZOLE, (RS)-
Systematic Name English
RABEPRAZOLE SODIUM IMPURITY H [EP IMPURITY]
Common Name English
CHLORO ANALOG [USP IMPURITY]
Common Name English
2-((RS)-((4-CHLORO-3-METHYLPYRIDIN-2-YL)METHYL)SULFINYL)-1H-BENZIMIDAZOLE
Systematic Name English
1H-BENZIMIDAZOLE, 2-(((4-CHLORO-3-METHYL-2-PYRIDINYL)METHYL)SULFINYL)-
Systematic Name English
RABEPRAZOLE RELATED COMPOUND F [USP-RS]
Common Name English
Code System Code Type Description
CAS
168167-42-8
Created by admin on Sat Dec 16 08:24:48 GMT 2023 , Edited by admin on Sat Dec 16 08:24:48 GMT 2023
PRIMARY
FDA UNII
2YP19K112N
Created by admin on Sat Dec 16 08:24:48 GMT 2023 , Edited by admin on Sat Dec 16 08:24:48 GMT 2023
PRIMARY
PUBCHEM
11335757
Created by admin on Sat Dec 16 08:24:48 GMT 2023 , Edited by admin on Sat Dec 16 08:24:48 GMT 2023
PRIMARY
EPA CompTox
DTXSID501158879
Created by admin on Sat Dec 16 08:24:48 GMT 2023 , Edited by admin on Sat Dec 16 08:24:48 GMT 2023
PRIMARY
RS_ITEM_NUM
1598075
Created by admin on Sat Dec 16 08:24:48 GMT 2023 , Edited by admin on Sat Dec 16 08:24:48 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966